Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Recurrent Bleeding in Hemorrhagic Moyamoya Disease : Prognostic Implications of the Perfusion Status

  • Jo, Kyung-Il (Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Min Soo (Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Yeon, Je Young (Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Jong-Soo (Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Hong, Seung-Chyul (Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2015.06.12
  • Accepted : 2015.10.19
  • Published : 2016.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : Hemorrhagic moyamoya disease (hMMD) is associated with a poor clinical course. Furthermore, poorer clinical outcomes occur in cases of recurrent bleeding. However, the effect of hemodynamic insufficiency on rebleeding risk has not been investigated yet. This study evaluated the prognostic implications of the perfusion status during the clinical course of adult hMMD. Methods : This retrospective study enrolled 52 adult hMMD patients between April 1995 and October 2010 from a single institute. Demographic data, clinical and radiologic characteristics, including hemodynamic status using single photon emission computed tomography (SPECT), and follow up data were obtained via a retrospective review of medical charts and imaging. Statistical analyses were performed to explore potential prognostic factors. Results : Hemodynamic abnormality was identified in 44 (84.6%) patients. Subsequent revascularization surgery was performed in 22 (42.3%) patients. During a 58-month (median, range 3-160) follow-up assessment period, 17 showed subsequent stroke (hemorrhagic n=12, ischemic n=5, Actuarial stroke rate $5.8{\pm}1.4%/year$). Recurrent hemorrhage was associated with decreased basal perfusion (HR 19.872; 95% CI=1.196-294.117) and omission of revascularization (10.218; 95%; CI=1.532-68.136). Conclusion : Decreased basal perfusion seems to be associated with recurrent bleeding. Revascularization might prevent recurrent stroke in hMMD by rectifying the perfusion abnormality. A larger-sized, controlled study is required to address this issue.

Keywords

References

  1. Baba T, Houkin K, Kuroda S : Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 79 : 900-904, 2008 https://doi.org/10.1136/jnnp.2007.130666
  2. Gross BA, Du R : Adult moyamoya after revascularization. Acta Neurochir (Wien) 155 : 247-254, 2013 https://doi.org/10.1007/s00701-012-1545-4
  3. Han JS, Abou-Hamden A, Mandell DM, Poublanc J, Crawley AP, Fisher JA, et al. : Impact of extracranial-intracranial bypass on cerebrovascular reactivity and clinical outcome in patients with symptomatic moyamoya vasculopathy. Stroke 42 : 3047-3054, 2011 https://doi.org/10.1161/STROKEAHA.111.615955
  4. Hwang K, Hwang G, Kwon OK : Endovascular embolization of a ruptured distal lenticulostriate artery aneurysm in patients with moyamoya disease. J Korean Neurosurg Soc 56 : 492-495, 2014 https://doi.org/10.3340/jkns.2014.56.6.492
  5. Kawaguchi S, Okuno S, Sakaki T : Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg 93 : 397-401, 2000 https://doi.org/10.3171/jns.2000.93.3.0397
  6. Kikuta K, Takagi Y, Nozaki K, Sawamoto N, Fukuyama H, Hashimoto N : The presence of multiple microbleeds as a predictor of subsequent cerebral hemorrhage in patients with moyamoya disease. Neurosurgery 62 : 104-111, discussion 111-112, 2008 https://doi.org/10.1227/01.NEU.0000311067.41239.E6
  7. Kobayashi E, Saeki N, Oishi H, Hirai S, Yamaura A : Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J Neurosurg 93 : 976-980, 2000 https://doi.org/10.3171/jns.2000.93.6.0976
  8. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y; Research Committee on Moyamoya Disease in Japan : Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease : results of multicenter survey in Japan. Stroke 38 : 1430-1435, 2007 https://doi.org/10.1161/STROKEAHA.106.478297
  9. Liu X, Zhang D, Shuo W, Zhao Y, Wang R, Zhao J : Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease. J Neurol Neurosurg Psychiatry 84 : 258-265, 2013 https://doi.org/10.1136/jnnp-2012-302236
  10. Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, et al. : Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease : results of the Japan Adult Moyamoya Trial. Stroke 45 : 1415-1421, 2014 https://doi.org/10.1161/STROKEAHA.113.004386
  11. Morioka M, Hamada J, Kawano T, Todaka T, Yano S, Kai Y, et al. : Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients. Stroke 34 : 90-95, 2003 https://doi.org/10.1161/01.STR.0000047120.67507.0D
  12. Nariai T, Matsushima Y, Imae S, Tanaka Y, Ishii K, Senda M, et al. : Severe haemodynamic stress in selected subtypes of patients with moyamoya disease : a positron emission tomography study. J Neurol Neurosurg Psychiatry 76 : 663-669, 2005 https://doi.org/10.1136/jnnp.2003.025049
  13. Okada Y, Shima T, Nishida M, Yamane K, Yamada T, Yamanaka C : Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya disease : cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. Stroke 29 : 625-630, 1998 https://doi.org/10.1161/01.STR.29.3.625
  14. Ryan RW, Chowdhary A, Britz GW : Hemorrhage and risk of further hemorrhagic strokes following cerebral revascularization in Moyamoya disease : a review of the literature. Surg Neurol Int 3 : 72, 2012 https://doi.org/10.4103/2152-7806.97730
  15. Saeki N, Nakazaki S, Kubota M, Yamaura A, Hoshi S, Sunada S, et al. : Hemorrhagic type moyamoya disease. Clin Neurol Neurosurg 99 Suppl 2 : S196-S201, 1997
  16. Starke RM, Komotar RJ, Connolly ES : Optimal surgical treatment for moyamoya disease in adults : direct versus indirect bypass. Neurosurg Focus 26 : E8, 2009
  17. Suzuki J, Takaku A : Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20 : 288-299, 1969 https://doi.org/10.1001/archneur.1969.00480090076012
  18. Yeon JY, Shin HJ, Kong DS, Seol HJ, Kim JS, Hong SC, et al. : The prediction of contralateral progression in children and adolescents with unilateral moyamoya disease. Stroke 42 : 2973-2976, 2011 https://doi.org/10.1161/STROKEAHA.111.622522
  19. Yoshida Y, Yoshimoto T, Shirane R, Sakurai Y : Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage : an extensive follow-up study. Stroke 30 : 2272-2276, 1999 https://doi.org/10.1161/01.STR.30.11.2272

Cited by

  1. Analysis of the clinical characteristics of hemorrhagic moyamoya disease in the Jilin province of northeastern China: A single-center study of 212 cases vol.8, pp.2, 2016, https://doi.org/10.3892/br.2017.1030
  2. Development of Targeted Alpha Particle Therapy for Solid Tumors vol.24, pp.23, 2016, https://doi.org/10.3390/molecules24234314
  3. Updates in the management of moyamoya disease vol.23, pp.None, 2021, https://doi.org/10.1016/j.inat.2020.100976